Jump to ContentJump to Main Navigation

Online

99,00 € / $149.00*

* Prices subject to change. Shipping costs will be added if applicable.
Publication Date:
April 2002
ISSN:
1935-1682
DOI:
10.2202/1538-0653.1007

See all formats and pricing

Online
Individual Subscription Online only
Euro [D] 99.00
RRP for USA, Canada, Mexico
US$ 149.00 *
Print
Individual Subscription Online only
Euro [D] 345.00
RRP for USA, Canada, Mexico
US$ 473.00 *
Print + Online
Individual Subscription Online only
Euro [D] 414.00
RRP for USA, Canada, Mexico
US$ 568.00 *
*Prices subject to change. Shipping costs will be added if applicable.

Ed. by Auriol , Emmanuelle / Brunner, Johann / Fleck, Robert / Friebel, Guido / Ludwig, Sandra / Requate, Till / Schneider, Hilmar / Tsui, Kevin / Wichardt, Philipp

2 Issues per year

IMPACT FACTOR 2011: 0.550

 

 

VolumeIssuePage

Cost Optimization in the SIS Model of Infectious Disease with Treatment

Steven Marc Goldman1 / James Lightwood2

1University of California, Berkeley, goldman@econ.berkeley.edu

2University of California, San Francisco, lightwo@itsa.ucsf.edu

Citation Information: Topics in Economic Analysis & Policy. Volume 2, Issue 1, Pages –, ISSN (Online) 1538-0653, DOI: 10.2202/1538-0653.1007, April 2002

Publication History:
Published Online:
2002-04-24

Abstract

We consider the intertemporal social optimization problem of minimizing the present value of the costs incurred from both disease and treatment. Though the analysis is complicated by the analytical failure of concavity, we are able to substantially characterize both the long run equilibria and the adjustment paths. The cost minimizing program is shown to exhibit decreased levels of treatment at higher disease levels. The socially optimal program is compared to individually rational behavior and the inefficiencies in private behavior from the infection externality are shown to cause increases in the equilibrium rate of infection.

Keywords: cost optimization; disease; intertemporal

Comments (0)

Please log in or register to comment.